The Association for Professionals in Infection Control and Epidemiology (APIC) is asking its members to petition Congressmembers to increase funding for the National Immunization Program at the Centers for Disease Control and Prevention (CDC), otherwise known as "section 317" of the Public Health Service Act.Â
Representatives Gene Green (D-TX) and John Shimkus (R-IL) have sent a Dear Colleague letter to every member of the House of Representatives asking them to sign on to a letter to the House Appropriations Committee to support increased funding for the National Immunization Program at the Centers for Disease Control and Prevention -- known as section 317 of the Public Health Service Act. The more members of the House of Representatives that sign on to the letter, the better chance the 317 Program will receive increased funding in the FY 2008 budget.
Concurrently, Senators Jack Reed (D-RI) and Gordon Smith (R-OR) have sent a similar Dear Colleague letter to every member of the Senate asking them to sign on to a letter to the Senate Appropriations Committee to support increased funding for the 317 Program. Again, the more members of the Senate that sign on to the letter, the better chance the 317 Program will receive increased funding. According to APIC, members of Congress are much more likely to sign on to these group letters if their constituents ask them to co-sign.Â
The letter asks that the 317 Program be funded at $802.5 million in fiscal year 2008, which is an increase of approximately $295 million over the last fiscal year. The Presidents budget request would cut the CDC immunization program in the appropriations bill by $12 million. Currently the program receives about $519 million in federal appropriations.Â
APIC is asking its members to request your member of Congress to sign the Dear Colleague letter.
Source: APIC
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.